Viewing StudyNCT00431210



Ignite Creation Date: 2024-05-05 @ 5:20 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00431210
Status: COMPLETED
Last Update Posted: 2017-04-18
First Post: 2007-02-02

Brief Title: Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Nasopharyngeal Carcinoma
Keywords:
Name View
NPC View
EPV View